Shanghai Sonyt Biotechnology Co., Ltd. yog ib qho ntawm cov ua lag luam thiab cov neeg muag khoom ntawm cas 1331848-79-3 alrefimotide hauv Suav teb, kuj txhawb kev pabcuam kev cai. Txais tos rau cov lag luam wholesale bulk zoo cas 1331848-79-3 alrefimotide los ntawm peb lub hoobkas. Tiv tauj peb kom paub meej ntxiv.
| CAS | 1331848-79-3 |
| Khoom npe | Alrefimotide |
| Qeb | Tumor Antigen Peptide / Vaccine Component |
| Purity (HPLC, %) | 95%/98%/99% |
| Cov mis mos molecular | C₇₈H₁₂₅N₂₃O₂₁ |
| Qhov nruab nrab molecular hnyav | 1736.99 Nws |
Product Basic Information Table
| Khoom Lub Npe Lus Askiv | Product Abbreviation / Alias | Function Tags (comma-sib cais) | Amino Acid Tag Nrho Lub Npe Sequence | Molecular Formula | Qhov hnyav Molecular (Da) | Qhov Nruab Nrab Molecular Luj (Da) | N-Terminal Hloov kho | C-Terminal Hloov kho | Qhov ntev (aa) |
| Alrefimotide | Alrefimotide; hTERT epitope peptide; Tshuaj tiv thaiv UV1; CAS Nr .: 1331848-79-3 | Tumor antigen peptide, CTL epitope peptide, Kev txhaj tshuaj tiv thaiv kab mob, Telomerase lub hom phiaj, qog tshuaj tiv thaiv kab mob, tshuaj tiv thaiv UV1 | Linear 15-amino acid peptide, hTERT- muab tau los ntawm MHC chav kawm I-restricted epitope peptide, muaj cov khoom seem hydrophobic anchor residues thiab cov seem tseem ceeb | C₇₈H₁₂₅N₂₃O₂₁ | 1735.91 | 1736.99 | Dawb amine, unmodified | Dawb carboxyl, unmodified | 15 |
Physicochemical Solubility & Cia Parameters
| Khoom Code | Qhov tshwm sim | Ntev - Lub Sij Hawm Cia Cov Cai | Luv -Lub Sijhawm Cia Cov Cai | Kua Stability | Khoom hmoov ruaj khov |
| PEB-ALR001 | hmoov dawb | Khaws ntawm -20 degree, tiv thaiv lub teeb, kaw thiab qhuav, aliquoted; zam rov qab khov-thaw cycles | Khoom hmoov ruaj khov rau 2 xyoos kaw thiab qhuav ntawm 2-8 degree; npaj aqueous daws freshly ua ntej siv, aliquots ruaj khov rau 1 lub hlis ntawm -20 degree | ruaj khov rau 72 h ntawm 4 degree; zam pH huab cua thiab qhov kub ntawm chav nyob ntev | ruaj khov rau 3 xyoos ntawm -20℃nyob rau hauv qhuav & tsaus ntuj |
Functional Description
| Khoom Code | Frontend Short Summary (rau cov npe tshawb nrhiav) | Cov lus piav qhia txog kev ua haujlwm lom neeg lom neeg | Cov cheeb tsam tshawb fawb (comma- cais) | Lub Hom Phiaj / Txoj Kev |
| PEB-ALR001 | hTERT- tau txais cov qog antigen peptide, feem ntawm cov tshuaj tiv thaiv UV1, siv rau CTL epitope validation thiab kev tshawb fawb tshuaj tiv thaiv qog | Alrefimotide yog MHC chav kawm I- txwv qog antigen peptide muab los ntawm hTERT. Nws tuaj yeem raug coj mus, ua tiav thiab nthuav tawm los ntawm antigen- nthuav tawm cov hlwb ntawm MHC chav kawm I molecules, yog li ua kom hTERT- tshwj xeeb CD8⁺ cytotoxic T cells. Activated T cells tuaj yeem paub thiab tua telomerase-cov qog nqaij hlav zoo. Alrefimotide feem ntau yog siv los ua kev tshawb fawb txog kev tshawb fawb tshuaj tiv thaiv qog nqaij hlav, tshwj xeeb tshaj yog nyob rau hauv cov tshuaj tiv thaiv UV1-txoj kev tshawb fawb, CTL epitope tshuaj ntsuam xyuas, T cell activation validation thiab kev tshawb nrhiav kev tiv thaiv kab mob sib xyaw ua ke. | Kev tshawb fawb qog noj tshuaj tiv thaiv kab mob qog noj ntshav, kev tsim tshuaj tiv thaiv qog nqaij hlav, T cell activation mechanism tshawb fawb, Telomerase tsom kev tshawb fawb, kev tshawb fawb txog kev tiv thaiv kab mob sib xyaw ua ke, CTL epitope tshuaj ntsuam | hTERT antigen epitope; MHC chav kawm I molecule kev nthuav qhia; CTL{0}}txoj kev kho mob qog cell tua kab mob |
Cim npe nrov: CAS 1331848-79-3 alrefimotide, Tuam Tshoj cas 1331848-79-3 alrefimotide manufacturers, lwm tus, Hoobkas
